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Open access uAssessment of long-term prognosis at detection of early
hepatocellular carcinoma remains unsolvedTo the Editor:
The study by Suh and coworkers [1] addresses a hot topic,
namely the possibility to predict prognosis (recurrence and sur-
vival) in patients submitted to curative treatments for early hepa-
tocellular carcinoma (HCC). The authors conclude that patients
submitted to radiofrequency ablation are at higher risk of local
intrahepatic recurrence in comparison to surgery and that sur-
vival is compromised in case of increased production of a-feto-
protein (AFP) by prothrombin, induced by vitamin K absence-II
(PIVKA-II), compared to all other groups (not increased AFP by
PIVKA-II product or surgical resection). We agree with the con-
clusion of the higher risk of recurrence, as we recently demon-
strated [2], but in our view the second conclusion is not
sufﬁciently supported by evidence. Moreover, some incorrect
reporting of data prevent a full understanding of the study.
Regarding the latter point, results about AFP and PIVKA-II were
reported as mean values. This is unacceptable, as such data are
not expected to follow a Gaussian distribution, thus, mean values
are poorly or totally non-informative or may even be misleading
under these circumstances. Median values have to be reported.
Moreover, readers cannot understand how many patients had
normal values of these two parameters. Secondly, the authors
themselves point out that patients submitted to ablation had a
slightly more compromised liver function than surgical patients.
It is evident that cirrhotic patients with poorer liver function have
a worse overall survival, regardless of the tumours status. We
have recently shown in this Journal that resection may apparently
provide better survival in early HCC, but only when entire patient
series are analysed [2]. Such difference disappeared in very early
HCC when patients were balanced in terms of background liver
function and tumour features [2]. Suh and colleagues [1] did
not show whether the four subgroups were superimposable in
terms of highly relevant factors, such as liver function variables,
tumour size and number, thus making the issue of survival
questionable. This would be recommendable, especially in the
two groups of patients, submitted to ablation, for which theReply to: ‘‘Assessment of long
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nder CC BY-NC-ND license.information, derived from histology on which prognosis was
designed, was not available. Thus, a re-analysis of the Korean data
appears to be well-deserved before the conclusions, proposed by
the authors, can be adopted.
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resection’’ [1]. Because of the higher risk of hepatocellular carci-
noma (HCC) recurrence after radiofrequency ablation (RFA), as
has been also recently demonstrated by the group of Piscaglia
[2], we investigated the predictors of aggressiveness in early-
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